RU2008115908A - PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE Download PDF

Info

Publication number
RU2008115908A
RU2008115908A RU2008115908/15A RU2008115908A RU2008115908A RU 2008115908 A RU2008115908 A RU 2008115908A RU 2008115908/15 A RU2008115908/15 A RU 2008115908/15A RU 2008115908 A RU2008115908 A RU 2008115908A RU 2008115908 A RU2008115908 A RU 2008115908A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
liposomes
composition containing
external use
containing hyaluronidase
Prior art date
Application number
RU2008115908/15A
Other languages
Russian (ru)
Other versions
RU2417097C2 (en
Inventor
Валерия Леонидовна Багирова (RU)
Валерия Леонидовна Багирова
Наталья Владимировна Глазова (RU)
Наталья Владимировна Глазова
Владимир Николаевич Иванов (RU)
Владимир Николаевич Иванов
Мария Дмитриевна Дулькис (RU)
Мария Дмитриевна Дулькис
Original Assignee
Валерия Леонидовна Багирова (RU)
Валерия Леонидовна Багирова
Наталья Владимировна Глазова (RU)
Наталья Владимировна Глазова
Владимир Николаевич Иванов (RU)
Владимир Николаевич Иванов
Мария Дмитриевна Дулькис (RU)
Мария Дмитриевна Дулькис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валерия Леонидовна Багирова (RU), Валерия Леонидовна Багирова, Наталья Владимировна Глазова (RU), Наталья Владимировна Глазова, Владимир Николаевич Иванов (RU), Владимир Николаевич Иванов, Мария Дмитриевна Дулькис (RU), Мария Дмитриевна Дулькис filed Critical Валерия Леонидовна Багирова (RU)
Priority to RU2008115908/15A priority Critical patent/RU2417097C2/en
Publication of RU2008115908A publication Critical patent/RU2008115908A/en
Application granted granted Critical
Publication of RU2417097C2 publication Critical patent/RU2417097C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Фармацевтическая композиция для местного применения, содержащая в в качестве активного ингредиента 2,00-2,44 мас.% гиалуронидазы, 2,00-2,93 мас.% твин-80, 91,00-92,19 мас.% ПЭГ-1500, 2,00-2,44 мас.% липосомы и фармацевтически приемлемые носители или эксципиенты. ! 2. Фармацевтическая композиция по п.1, дополнительно содержащая один или более чем один противовоспалительный ингредиент.1. A pharmaceutical composition for topical application, containing as an active ingredient 2.00-2.44 wt.% Hyaluronidase, 2.00-2.93 wt.% Tween-80, 91.00-92.19 wt.% PEG-1500, 2.00-2.44 wt.% Liposomes and pharmaceutically acceptable carriers or excipients. ! 2. The pharmaceutical composition according to claim 1, additionally containing one or more than one anti-inflammatory ingredient.

Claims (2)

1. Фармацевтическая композиция для местного применения, содержащая в в качестве активного ингредиента 2,00-2,44 мас.% гиалуронидазы, 2,00-2,93 мас.% твин-80, 91,00-92,19 мас.% ПЭГ-1500, 2,00-2,44 мас.% липосомы и фармацевтически приемлемые носители или эксципиенты.1. A pharmaceutical composition for topical application, containing as an active ingredient 2.00-2.44 wt.% Hyaluronidase, 2.00-2.93 wt.% Tween-80, 91.00-92.19 wt.% PEG-1500, 2.00-2.44 wt.% Liposomes and pharmaceutically acceptable carriers or excipients. 2. Фармацевтическая композиция по п.1, дополнительно содержащая один или более чем один противовоспалительный ингредиент. 2. The pharmaceutical composition according to claim 1, additionally containing one or more than one anti-inflammatory ingredient.
RU2008115908/15A 2008-04-24 2008-04-24 Pharmaceutical composition containing hyaluronidase and liposomes for external application RU2417097C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008115908/15A RU2417097C2 (en) 2008-04-24 2008-04-24 Pharmaceutical composition containing hyaluronidase and liposomes for external application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008115908/15A RU2417097C2 (en) 2008-04-24 2008-04-24 Pharmaceutical composition containing hyaluronidase and liposomes for external application

Publications (2)

Publication Number Publication Date
RU2008115908A true RU2008115908A (en) 2009-10-27
RU2417097C2 RU2417097C2 (en) 2011-04-27

Family

ID=41352671

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008115908/15A RU2417097C2 (en) 2008-04-24 2008-04-24 Pharmaceutical composition containing hyaluronidase and liposomes for external application

Country Status (1)

Country Link
RU (1) RU2417097C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2586305C1 (en) * 2015-02-02 2016-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Method of treating obstructive azoospermia and cryptozoospermia in patients with chronic prostatitis
RU2616528C1 (en) * 2015-12-04 2017-04-17 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" Method for preparing conjugate of hyaluronidase with derivatives of polyethylene piperazine and application of produced conjugate
RU2752588C2 (en) * 2019-10-02 2021-07-29 Общество с ограниченной ответственностью "Самсон-Мед" Preparation for treatment of prostatic gland diseases made in form of a suppository

Also Published As

Publication number Publication date
RU2417097C2 (en) 2011-04-27

Similar Documents

Publication Publication Date Title
ECSP055528A (en) PHARMACEUTICAL COMPOSITION THAT HAS A UNIFORM DISTRIBUTION AND POWER OF FARMACO
WO2009072007A3 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
UA105766C2 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
NO20091395L (en) New thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
MY154909A (en) Novel thiophene derivatives
CL2011000170A1 (en) Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation.
TW200942524A (en) Novel aminomethyl benzene derivatives
MX2009007784A (en) Compositions of stable tiacumicins.
RS53515B1 (en) Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention of treatment of chronic venous insufficiency
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
AR078283A1 (en) ORAL SUSPENSION FORMULATIONS OF DIBENZAZEPINA CARBOXAMIDAS
EP4241855A3 (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
EP2316420A8 (en) Method to reduce pain
SA519401614B1 (en) Novel naphthyridinone derivatives and their use in the treatment of arrhythmia
RU2008115908A (en) PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE
EP2611799A4 (en) Pharmaceutical compositions of linezolid
EA201100104A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
DK1660495T3 (en) Benzoquinolizin-2-carboxylsyreargininsalt tetrahydrate
CY1114028T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF WRENCHES

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100504

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20100705

MM4A The patent is invalid due to non-payment of fees

Effective date: 20110314

NF4A Reinstatement of patent

Effective date: 20120527